| Name | Title | Contact Details |
|---|
abeo is a nationwide medical billing and software company focused on delivering revenue-enhancing services to private practices, hospitals and surgery centers. We bridge the gap between the constant change in healthcare and your changing needs as a result. We know the healthcare landscape; we know the complexities and regulations. Our professional management services, medical billing software and anesthesia advisory services are tailored to improve the operational and financial performance for the specialty of anesthesiology. We blend our employee expertise in anesthesia with process and technology to take efficiency to the next level. Operational best practices play a key role in our ability to provide the quality of service clients receive and have come to expect from abeo. Our clients know their best interest is at the center of abeo doing their job, and doing it well.
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
KAI Research is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fifty-Plus Lifelong Fitness is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eos is a leading beauty and skincare brand that originated around a key insight, women want products that deliver moments of delight that transcend daily routines. From its iconic lip balm to hand and body lotion to shave cream, Eos products are hypoallergenic, dermatologist-tested, gluten-free, and packed with nourishing vitamins and natural skin-conditioning oils.